(Q35982031)

English

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer (English)

1 reference

Europe PubMed Central

11 August 2017

author name string

Stein RC

1

1 reference

Europe PubMed Central

11 August 2017

Dowsett M

2

1 reference

Europe PubMed Central

11 August 2017

Hedley A

3

1 reference

Europe PubMed Central

11 August 2017

Gazet JC

4

1 reference

Europe PubMed Central

11 August 2017

Ford HT

5

1 reference

Europe PubMed Central

11 August 2017

Coombes RC

6

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 October 1990

1 reference

Europe PubMed Central

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

11 August 2017

62

1 reference

Europe PubMed Central

11 August 2017

679-683

1 reference

Europe PubMed Central

11 August 2017

4

1 reference

Europe PubMed Central

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1990.356

0 references

Regulation of estrogen biosynthesis by human adipose cells in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Potent agonist and antagonist analogues of luliberin containing an azaglycine residue in position 10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

Aminoglutethimide in treatment of metastatic breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

2 October 2017

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Effect of treatment with aromatase inhibitor 4-hydroxandrostenedione on the nonhuman primate menstrual cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

11 July 2018

Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971476

24 September 2018

In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of the ovary to blockade of aromatization with aminoglutethimide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral aromatase as a prognostic factor in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Menopausal Transition: Analysis of LH, FSH, Estradiol, and Progesterone Concentrations During Menstrual Cycles of Older Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1990.356

1 reference

Europe PubMed Central

11 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35982031&oldid=1984022872"